What Is Melanotan II?

Overview

Melanotan II is a synthetic, cyclic peptide engineered to imitate the signalling of alpha-melanocyte-stimulating hormone (alpha-MSH), a natural ligand for the melanocortin receptors. Because it is more potent and far more metabolically stable than the native hormone, it has become a standard probe in laboratory work that examines how melanocortin signalling drives pigment production and several central pathways. Its appeal in research settings comes from its non-selective reach: rather than acting on a single receptor, it engages multiple members of the melanocortin family, which lets investigators model the system as a whole.

How Melanotan II Works

The compound is an agonist at the melanocortin receptors, a family of five G-protein-coupled receptors (MC1R through MC5R). Activation of MC1R on melanocytes stimulates the production of eumelanin, the pigment pathway that underlies the compound's well-documented effect on skin coloration in research models. Engagement of the centrally expressed receptors — chiefly MC3R and MC4R — links the molecule to studies of appetite and energy balance, while MC4R signalling has also been explored in the context of sexual-arousal pathways. Its cyclic structure resists enzymatic breakdown, giving it a longer functional half-life than endogenous alpha-MSH and making it practical for sustained experimental exposure.

What the Research Explores

• Melanocortin-1-receptor signalling and the regulation of melanin synthesis in cutaneous models.
• Central melanocortin pathways governing appetite and energy homeostasis (MC3R/MC4R).
• MC4R-mediated mechanisms relevant to erectile and sexual-arousal research.
• Structure-activity relationships of cyclic alpha-MSH analogs versus the native hormone.

Forms & Handling

Melanotan II is typically supplied as a lyophilized powder in vial sizes of 10 mg, 20 mg or 30 mg. For laboratory use it is reconstituted with bacteriostatic or sterile water; as an example, adding 2 mL of diluent to a 10 mg vial yields a 5 mg/mL solution. The dry powder is stable when stored cool and protected from light, and once reconstituted the solution should be refrigerated and used within a limited window. See the dosing protocols below for reconstitution math expressed in insulin-syringe units.

Safety & Research Notes

Melanotan II is an investigational research compound with no approved human or veterinary use and no established safety profile for administration. Several national regulators have issued public safety alerts about unapproved products marketed under this name. The published literature is confined to laboratory and limited pre-clinical or early-phase contexts; anything described here is mechanistic background, not a usage recommendation.

References

Related Protocols